Helping an oncology company with a preclinical project to seek finance and potential acquisition

Challenge A virtual life science company had raised money from angel investors and anticipated a clinical development strategy for their product targeting two major cancer indications. The client...
Learn More

Matching sellers with buyers for a wound care product

Challenge A company developing a novel wound care product was embarking on a significant clinical trial program. It was planning an investor exit in the next 24 months and therefore wanted to connect...
Learn More

Providing business development and deal support in antibiotics

Challenge A pharma company that specializes in discovering and developing antibiotics asked us to help expand the search for a development partner in some of its drug candidates.
Learn More

Valuing a cancer immunotherapy asset

Challenge A biotech company developing a cell-based cancer immunotherapy was engaged in licensing discussions with a number of major pharma companies and needed valuation support.
Learn More

Valuing multinational pharma company partnerships

Challenge A division of a multinational pharma company needed to evaluate a pipeline agreement with an antibody platform technology company. They wished to understand the overall value of the...
Learn More

Supporting a biotech company’s pharma partnerships

Challenge A biotech company needed support with an active partnering process with several major pharma companies.
Learn More

Evaluating a pipeline agreement with a platform technology company

Challenge A division of a multinational pharma company needed support evaluating a pipeline agreement with a platform technology company. The client wanted to know what the overall value of this...
Learn More

Conducting due diligence on a novel interventional cardiology device

Challenge A university research team had worked for a number of years on the development of a novel interventional cardiology device. Recent progress had been made with preclinical testing on pigs,...
Learn More

Due diligence on a new biosensor technology

Challenge A company considering an investment in a new early-stage biosensor technology for the measurement of blood pressure needed due diligence support. The product had a number of potential...
Learn More

Providing an oncology cell therapy reality check

Challenge A venture capital investor needed a reality check on a clinical stage cancer biologic prior to a proposed $10m investment.
Learn More

Due diligence of a small molecule arising from a phenotypic screen

Challenge Our client asked us to conduct a risk assessment and due diligence of a small molecule oncology compound that had been identified from a phenotypic screen. The molecule was in a Phase I/II...
Learn More

Due diligence and valuation of a preclinical kinase inhibitor

Challenge We were commissioned to conduct a comprehensive technical risk assessment and due diligence of a novel preclinical, small molecule, kinase inhibitor.
Learn More